semaglutide vs. phentermine vs semaglutide: Which weight loss drug is right for you? Phentermine vs Semaglutide vs Tirzepatide

Many initial reactions do not recur with subsequent injections, especially when technique improves and sites are properly rotated

Key Takeaways No commercial retatrutide pen exists: Eli Lilly has not FDA-approved or publicly released any branded retatrutide auto-injector as of May 2026 Phase 3 TRIUMPH trials confirm subcutaneous injection once weekly, but the specific device format has not been disclosed by Lilly Grey-market pens are not Lilly products: The "SALKALLI" DailyMed entry is a Chinese export-only product (Guangzhou Yixin Co.), not FDA-approved for US use Phase 3 TRIUMPH-4 results showed 28.7% weight loss at 68 weeks on 12mg, the strongest obesity trial result on record When approved (2027 earliest), a once-weekly auto-injector similar to Lilly's KwikPen format is widely anticipated Use the retatrutide pharmacokinetic calculator to plan dosing regardless of delivery format 28.7% Phase 3 TRIUMPH-4 Weight Loss ~6 days Half-Life (Once-Weekly Dosing) 12mg Maximum Dose (Phase 3) 2027 Earliest Likely US Launch Does Retatrutide Come in a Pen

This dual mechanism is believed to offer a synergistic effect, potentially leading to greater weight loss efficacy compared to single-agonist therapies

These blueprints typically focus on diet and exercise but may also include other plans